November 25, 2011 -- Kunming Pharmaceutical will partner with Heilongjiang ZBD Pharmaceutical to develop Sanqi Panax Notoginseng for Injection (freeze-drying), a TCM used for blood disorders. Each party will contribute IP that they own or “are about to own” to the collaboration. The reason behind the “about to own” phrase was not made clear. Panax Notoginseng is prescribed to promote hemostasis, blood production and blood thinning. More details....
Stock Symbol: (SHA: 600422)
